Cargando…

Role of maximum androgen blockade in advanced prostate cancer

Androgen ablation is the mainstay treatment for advanced prostate cancer (PC). Researchers proposed that maximum androgen blockade (MAB) therapy with antiandrogen agent in combination with castration might result in a better outcome among patients with advanced PC. In the last two decades, numerous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayyathurai, Rajinikanth, Santos, Rosely De Los, Manoharan, Murugesan
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684298/ https://www.ncbi.nlm.nih.gov/pubmed/19468428 http://dx.doi.org/10.4103/0970-1591.45536

Ejemplares similares

Delayed Local Recurrence Following Radiation Therapy for Muscle-Invasive Bladder Cancer Emphasizing the Need for Lifelong Surveillance: a Case Report
por: Sunkara, Rajitha, et al.
Publicado: (2008)

Current concepts in the management of adrenal incidentalomas
por: Kanagarajah, Prashanth, et al.
Publicado: (2012)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Prospective randomized comparison of the safety, efficacy, and cosmetic outcome associated with mini-transverse and mini-longitudinal radical prostatectomy incisions
por: Kava, Bruce R., et al.
Publicado: (2010)

Maximal androgen blockade for advanced prostate cancer
por: Mukha, Rajiv Paul, et al.
Publicado: (2010)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Efficacy of Alternative Antiandrogen Therapy for Prostate Cancer That Relapsed after Initial Maximum Androgen Blockade
por: Choi, Joon Il, et al.
Publicado: (2011)

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016)

Monitoring of the upper urinary tract in patients with bladder cancer
por: Ayyathurai, Rajinikanth, et al.
Publicado: (2011)

Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports
por: Hingorani, Mohan, et al.
Publicado: (2014)

Development of a surgical safety checklist for the performance of radical nephrectomy and tumor thrombectomy
por: Joshi, Shivam, et al.
Publicado: (2012)

Maximal androgen blockade for the treatment of metastatic prostate cancer—a systematic review
por: Lukka, H., et al.
Publicado: (2006)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer
por: Tamada, Satoshi, et al.
Publicado: (2018)

Predicting castration-resistant prostate cancer after combined androgen blockade
por: He, Miao, et al.
Publicado: (2017)

Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer
por: Kang, Yu Jin, et al.
Publicado: (2014)

The role of 11-oxygenated androgens in prostate cancer
por: Snaterse, Gido, et al.
Publicado: (2023)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
por: Tan, Kah Ni, et al.
Publicado: (2020)

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
por: Shore, Neal D., et al.
Publicado: (2020)

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer
por: Kiper, Ahmet, et al.
Publicado: (2005)

Loss and revival of androgen receptor signaling in advanced prostate cancer
por: Formaggio, Nicolò, et al.
Publicado: (2021)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination
por: Lee, Sung Uk, et al.
Publicado: (2017)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
por: Lückerath, Katharina, et al.
Publicado: (2018)

The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer
por: Shamaladevi, Nagarajarao, et al.
Publicado: (2016)

The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer
por: Nieder, Alan M., et al.
Publicado: (2006)

Prostate cancer stem cells: the role of androgen and estrogen receptors
por: Di Zazzo, Erika, et al.
Publicado: (2015)

Androgen receptor: structure, role in prostate cancer and drug discovery
por: Tan, MH Eileen, et al.
Publicado: (2015)

One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling
por: Corbin, Joshua M., et al.
Publicado: (2016)

Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer
por: Miller, Katie Joanna, et al.
Publicado: (2022)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Feasibility of renal transplantation after unroofing of a large renal cyst in an expanded criteria donor
por: Kanagarajah, Prashanth, et al.
Publicado: (2013)

An Unusual Complication of Suprapubic Catheter Insertion
por: Ananthakrishnan, Krishnan, et al.
Publicado: (2006)

Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2021)

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gtpc8c0mu1ikfb844q4ue9lm3k